Rheumatoid arthritis Trials in Kortrijk, Belgium
Conditions / Rheumatoid arthritis / Kortrijk, Belgium
Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01142726 | Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT01331837 | A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors | COMPLETED | PHASE4 |
| NCT01274182 | GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy | COMPLETED | PHASE1/PHASE2 |
| NCT01521923 | A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT01426789 | A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients | COMPLETED | PHASE2 |
| NCT01888874 | Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1) | COMPLETED | PHASE2 |
| NCT01636817 | A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics | TERMINATED | PHASE2 |
| NCT01636843 | A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate | TERMINATED | PHASE2 |
| NCT00234884 | Post-marketing Observational Study in Subjects With Rheumatoid Arthritis | COMPLETED | — |
| NCT01519791 | A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis | COMPLETED | PHASE3 |